US equities
|
NVDA
$239.54
▲+2.39%
SPCX
$169.74
▲+6.78%
MU
$1,061.28
▼-1.27%
TSLA
$380.51
▲+2.68%
SNDK
$1,695.45
▼-1.43%
MSFT
$528.60
▲+2.14%
INTC
$116.42
▼-2.44%
META
$743.93
▲+2.18%
NVDA
$239.54
▲+2.39%
SPCX
$169.74
▲+6.78%
MU
$1,061.28
▼-1.27%
TSLA
$380.51
▲+2.68%
SNDK
$1,695.45
▼-1.43%
MSFT
$528.60
▲+2.14%
INTC
$116.42
▼-2.44%
META
$743.93
▲+2.18%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
ImmunoGen, Inc. - Common Stock
(NQ:
IMGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ImmunoGen, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
↗
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Earnings Scheduled For May 10, 2021
↗
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2021
From
ImmunoGen Inc.
Via
Business Wire
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2021 Operating Results
April 26, 2021
From
ImmunoGen Inc.
Via
Business Wire
ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting
April 10, 2021
From
ImmunoGen Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
